GIP (Human)

• Description:

  GIP (Human) Catalog number: MDP0563 CAS Number: N/A Sequence: Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln Amount: 500 ug Molecular Weight: 4983.2 g/mol Supplied as: Powder Applications: molecular tool for various biochemical applications Storage: -20 °C WARNING: For in vitro Research Use Only. NOT for use on humans or animals. Grade: Biotechnology grade. All products are highly pure. References: 1: Nauck MA, Quast DR, Wefers J, Pfeiffer AFH. The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update Diabetes Obes Metab. 2021 Sep;23 Suppl 3:5-29. 2: Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP Gastroenterology. 2007 May;132(6):2131-57. 3: Hammoud R, Drucker DJ. Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1 Nat Rev Endocrinol. 2023 Apr;19(4):201-216. 4: Masaki T, Kodera Y, Terasaki M, Fujimoto K, Hirano T, Shichiri M. GIP_HUMAN-29 is a new proatherogenic peptide identified by native plasma peptidomics Sci Rep. 2021 Jul 14;11(1):14470. 5: Knerr PJ, Mowery SA, Douros JD, Premdjee B, Hjøllund KR, He Y, Kruse Hansen AM, Olsen AK, Perez-Tilve D, DiMarchi RD, Finan B. Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice Mol Metab. 2022 Sep;63:101533. 6: Regazzo D, Barbot M, Scaroni C, Albiger N, Occhi G. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes Rev Endocr Metab Disord. 2020 Mar;21(1):165-183. 7: Thondam SK, Cuthbertson DJ, Wilding JPH. The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD) Peptides. 2020 Mar;125:170208. 8: Holst JJ. The incretin system in healthy humans: The role of GIP and GLP-1 Metabolism. 2019 Jul;96:46-55. 9: Lindquist P, Gasbjerg LS, Mokrosinski J, Holst JJ, Hauser AS, Rosenkilde MM. The Location of Missense Variants in the Human GIP Gene Is Indicative for Natural Selection Front Endocrinol (Lausanne). 2022 Jun 29;13:891586. 10: Fisman EZ, Tenenbaum A. The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect Cardiovasc Diabetol. 2021 Nov 24;20(1):225.
  Products Related to GIP (Human) can be found at Peptides

• Short Description:

  Catalog Number: MDP0563 (500 ug)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5